Edwards Martin

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 43% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Edwards Martin's trades of Verona Pharma PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
365.41
Quantity 94,612 +22.9%
Value US$4,723,808
Transaction date
Purchase
Price
162.55
Quantity 87,464 -24.9%
Value US$545,713
Transaction date
Purchase
Price
369.86
Quantity 75,322 +22.3%
Value US$1,208,784
Transaction date
Planned sale
Price
0.99
Quantity 13,688 -10.0%
Value US$13,603
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-05 2025-08-01
S Sale
94,612 +22.9%
365.41
US$4,723,808 		94,612 +22.9% 365.41 US$4,723,808
2023-11-22 2023-11-20
B Purchase
87,464 -24.9%
162.55
US$545,713 		87,464 -24.9% 162.55 US$545,713
2023-11-15 2023-11-13
B Purchase
75,322 +22.3%
369.86
US$1,208,784 		75,322 +22.3% 369.86 US$1,208,784
2021-02-03 2021-02-01
PlS Planned sale
13,688 -10.0%
0.99
US$13,603 		13,688 -10.0% 0.99 US$13,603